Solasia Pharma KK
TSE:4597
Solasia Pharma KK
TSE:4597
Price:
32
JPY
Market Closed
Market Cap:
¥8.7B
Balance Sheet
Balance Sheet Decomposition
Solasia Pharma KK
Solasia Pharma KK
Balance Sheet Decomposition is not available for
Solasia Pharma KK
Solasia Pharma KK
Balance Sheet
Solasia Pharma KK
Solasia Pharma KK
Currency: JPY
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
501
|
2 100
|
1 039
|
3 370
|
4 046
|
4 116
|
2 964
|
714
|
803
|
728
|
886
|
1 387
|
|
| Cash Equivalents |
501
|
2 100
|
1 039
|
3 370
|
4 046
|
4 116
|
2 964
|
714
|
803
|
728
|
886
|
1 387
|
|
| Total Receivables |
13
|
13
|
2
|
19
|
193
|
10
|
173
|
126
|
572
|
67
|
232
|
374
|
|
| Accounts Receivables |
0
|
0
|
0
|
5
|
145
|
4
|
77
|
87
|
542
|
36
|
29
|
374
|
|
| Other Receivables |
0
|
0
|
0
|
14
|
48
|
6
|
96
|
39
|
30
|
31
|
203
|
0
|
|
| Inventory |
0
|
0
|
68
|
93
|
122
|
3
|
4
|
0
|
14
|
122
|
128
|
112
|
|
| Other Current Assets |
9
|
12
|
15
|
43
|
143
|
173
|
128
|
54
|
46
|
59
|
20
|
17
|
|
| Total Current Assets |
523
|
2 125
|
1 123
|
3 525
|
4 504
|
4 302
|
3 269
|
894
|
1 435
|
976
|
1 266
|
1 890
|
|
| PP&E Net |
1
|
2
|
1
|
1
|
58
|
112
|
102
|
120
|
63
|
81
|
47
|
113
|
|
| PP&E Gross |
1
|
2
|
1
|
1
|
58
|
112
|
102
|
120
|
63
|
81
|
47
|
0
|
|
| Accumulated Depreciation |
2
|
3
|
4
|
4
|
9
|
18
|
31
|
41
|
40
|
32
|
36
|
0
|
|
| Intangible Assets |
1 349
|
1 987
|
2 575
|
3 085
|
3 123
|
3 485
|
2 356
|
2 079
|
1 570
|
1 117
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
6
|
1
|
0
|
|
| Other Long-Term Assets |
5
|
5
|
5
|
43
|
43
|
47
|
48
|
51
|
55
|
49
|
48
|
142
|
|
| Total Assets |
1 879
N/A
|
4 119
+119%
|
3 705
-10%
|
6 655
+80%
|
7 728
+16%
|
7 946
+3%
|
5 775
-27%
|
3 144
-46%
|
3 134
0%
|
2 229
-29%
|
1 362
-39%
|
2 145
+57%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
987
|
386
|
1
|
213
|
1
|
229
|
|
| Accrued Liabilities |
6
|
11
|
20
|
27
|
30
|
32
|
36
|
36
|
26
|
34
|
37
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
41
|
1 039
|
47
|
37
|
33
|
25
|
31
|
|
| Other Current Liabilities |
159
|
150
|
207
|
385
|
589
|
852
|
17
|
20
|
343
|
226
|
130
|
52
|
|
| Total Current Liabilities |
165
|
161
|
227
|
412
|
619
|
925
|
2 079
|
489
|
407
|
293
|
193
|
312
|
|
| Long-Term Debt |
1 321
|
2 867
|
0
|
0
|
0
|
27
|
21
|
37
|
0
|
27
|
0
|
64
|
|
| Deferred Income Tax |
130
|
63
|
43
|
34
|
11
|
65
|
11
|
18
|
53
|
22
|
0
|
5
|
|
| Other Liabilities |
9
|
29
|
1
|
1
|
11
|
12
|
12
|
13
|
12
|
12
|
13
|
12
|
|
| Total Liabilities |
1 625
N/A
|
3 120
+92%
|
272
-91%
|
447
+64%
|
641
+44%
|
1 029
+61%
|
2 123
+106%
|
557
-74%
|
472
-15%
|
354
-25%
|
206
-42%
|
393
+91%
|
|
| Equity | |||||||||||||
| Common Stock |
1 872
|
2 572
|
4 053
|
5 963
|
7 632
|
960
|
1 402
|
2 110
|
1 436
|
1 596
|
2 211
|
836
|
|
| Retained Earnings |
3 428
|
4 072
|
4 546
|
5 554
|
7 975
|
1 400
|
2 717
|
5 201
|
220
|
1 335
|
3 277
|
521
|
|
| Additional Paid In Capital |
1 810
|
2 500
|
3 929
|
5 802
|
7 483
|
4 630
|
5 043
|
5 738
|
1 500
|
1 657
|
2 255
|
1 455
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
48
|
70
|
70
|
70
|
70
|
69
|
65
|
65
|
|
| Other Equity |
0
|
1
|
3
|
2
|
5
|
3
|
6
|
10
|
16
|
26
|
32
|
47
|
|
| Total Equity |
254
N/A
|
999
+294%
|
3 433
+244%
|
6 209
+81%
|
7 087
+14%
|
6 917
-2%
|
3 652
-47%
|
2 587
-29%
|
2 662
+3%
|
1 875
-30%
|
1 156
-38%
|
1 752
+52%
|
|
| Total Liabilities & Equity |
1 879
N/A
|
4 119
+119%
|
3 705
-10%
|
6 655
+80%
|
7 728
+16%
|
7 946
+3%
|
5 775
-27%
|
3 144
-46%
|
3 134
0%
|
2 229
-29%
|
1 362
-39%
|
2 145
+57%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
58
|
71
|
65
|
88
|
105
|
116
|
123
|
134
|
168
|
174
|
218
|
263
|
|
Switch to:
Switch to:
See Also
Discover More
